CRISPR Therapeutics AG

Report date
3/31/2026
Quarter
2026 Q1
Filed
4/15/2026
Shares
2,140
Value ($000)
102
Weight
0.0%
2024 Q4 - 2026 Q1 (6 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).